Author: Evan Dion

Indivior Shares Lower After Cutting Opioid Drug Sales Forecast

Indivior Shares Lower After Cutting Opioid Drug Sales Forecast

Shares of Indivior (INDV.L) traded sharply lower early Thursday as the British drugmaker cut the sales outlook for Sublocade, a treatment for opioid use disorder, saying it “substantially underestimated” the lag time associated with the approval of medical benefits coverage of individual patients. Net sales from Sublocade in the fiscal third quarter are likely to be $3 to $4 million, […]